Cilostazol
9 NDCs across 4 manufacturers|9 Generic,0 Brand
Cilostazol is used to treat vascular graft occlusion, intermittent claudication and peripheral vascular diseases, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 15, 1999, and the first generic was approved Nov 23, 2004. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $17 million on Cilostazol across 796,000 claims for 201,000 beneficiaries.
Cilostazol is available as 9 NDCs from 4 manufacturers (9 generic, 0 brand), with NADAC prices from $0.12 to $0.13 per EA — a 10% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
4
competing in market
Price Spread
$0.12 – $0.13
per EA
7d Activity
avg +1.3% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing CILOSTAZOL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CILOSTAZOL 100 MG TABLET | $0.1346 per EA | +1.47% |
CILOSTAZOL 100 MG TABLET | $0.1346 per EA | +1.47% |
CILOSTAZOL 100 MG TABLET | $0.1346 per EA | +1.47% |
CILOSTAZOL 100 MG TABLET | $0.1346 per EA | +1.47% |
CILOSTAZOL 100 MG TABLET | $0.1346 per EA | +1.47% |
CILOSTAZOL 50 MG TABLET | $0.1219 per EA | +1.17% |
CILOSTAZOL 50 MG TABLET | $0.1219 per EA | +1.17% |
CILOSTAZOL 50 MG TABLET | $0.1219 per EA | +1.17% |
CILOSTAZOL 50 MG TABLET | $0.1219 per EA | +1.17% |
Frequently Asked Questions
What is Cilostazol used to treat?
Cilostazol is used to treat vascular graft occlusion, intermittent claudication and peripheral vascular diseases, per the National Library of Medicine's MED-RT classification.
When did Cilostazol become available as a generic?
FDA approved the first generic Cilostazol (ANDA) on Nov 23, 2004. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cilostazol?
In 2024, Medicare Part D spent $17 million on Cilostazol across 796,000 claims for 201,000 beneficiaries.
How many Cilostazol products are on the market?
The Cilostazol drug market contains 9 NDCs from 4 manufacturers — 9 generic and 0 brand products.
What is the price range for Cilostazol?
NADAC reference prices for Cilostazol range from $0.1219 to $0.1346 per EA — a 10% difference between cheapest and most expensive.
Which manufacturers make Cilostazol?
4 manufacturers list Cilostazol in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (3), Slate Run Pharmaceuticals LLC (2), AvPAK (2), Apotex Corp. (2).
How has the price of Cilostazol changed recently?
Over the past 7 days, 9 Cilostazol NDCs rose and 0 fell, with a market-wide average change of +1.3%.